Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials

BACKGROUND: Lopinavir-ritonavir is a repurposed drug for coronavirus disease-2019 (COVID-19). In this study, a pooled effect of lopinavir-ritonavir on mortality, virological cure, radiological improvement and safety profile in COVID-19 patients has been evaluated. METHODS: The databases were searche...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Tejas K., Patel, Parvati B., Barvaliya, Manish, Saurabh, Manoj Kumar, Bhalla, Hira Lal, Khosla, Prem Parkash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056786/
https://www.ncbi.nlm.nih.gov/pubmed/34020215
http://dx.doi.org/10.1016/j.jiph.2021.03.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056786/
https://www.ncbi.nlm.nih.gov/pubmed/34020215
http://dx.doi.org/10.1016/j.jiph.2021.03.015

Ejemplares similares